Completed
A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer
NCT02640365
- Conditions
- Neoplasms, Unresectable Advanced Cancer
- Locations
-
- Hôpital Saint Antoine Paris, France